{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:46:23Z","timestamp":1790009183204,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00277-024-06021-2","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T20:16:17Z","timestamp":1728418577000},"page":"4731-4739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9432-224X","authenticated-orcid":false,"given":"Alessandro","family":"Lagan\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Fucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7181-447X","authenticated-orcid":false,"given":"Cristina","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2803-3766","authenticated-orcid":false,"given":"Silvio","family":"Ligia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Mormile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erminia","family":"Baldacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2593-1376","authenticated-orcid":false,"given":"Antonio","family":"Chistolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"issue":"9159","key":"6021_CR1","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","volume":"353","author":"FR Rosendaal","year":"1999","unstructured":"Rosendaal FR (1999) Venous thrombosis: a multicausal disease. The Lancet 353(9159):1167\u20131173","journal-title":"The Lancet"},{"issue":"6","key":"6021_CR2","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1378\/chest.09-0757","volume":"136","author":"F Couturaud","year":"2009","unstructured":"Couturaud F, Leroyer C, Julian JA et al (2009) Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. Chest J 136(6):1537\u20131545","journal-title":"Chest J"},{"key":"6021_CR3","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","volume":"293","author":"SC Christiansen","year":"2005","unstructured":"Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293:2352\u20132361","journal-title":"JAMA"},{"key":"6021_CR4","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1016\/S2352-3026(20)30211-8","volume":"7","author":"ND Klemen","year":"2020","unstructured":"Klemen ND, Feingold PL, Hashimoto B, Wang M, Kleyman S, Brackett A, Gross CP, Pei KY (2020) Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis. Lancet Haematol 7:e583\u2013e593","journal-title":"Lancet Haematol"},{"issue":"2","key":"6021_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/j.seminhematol.2007.02.004","volume":"44","author":"M Cushman","year":"2007","unstructured":"Cushman M (2007) Epidemiology and risk factors for venous thrombosis. Semin Hematol 44(2):62\u201369","journal-title":"Semin Hematol"},{"key":"6021_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.thromres.2016.11.023","volume":"149","author":"A Garcia-Horton","year":"2017","unstructured":"Garcia-Horton A, Kovacs MJ, Abdulrehman J, Taylor JE, Sharma S, Lazo-Langner A (2017) Impact of thrombophilia screening on venous thromboembolism management practices. Thromb Res 149:76\u201380","journal-title":"Thromb Res"},{"key":"6021_CR7","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1182\/blood-2008-10-184879","volume":"113","author":"WM Lijfering","year":"2009","unstructured":"Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, Hamulyak K, Prins MH, Buller HR, van der Meer J (2009) Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood 113:5314\u20135322","journal-title":"Blood"},{"key":"6021_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7326\/0003-4819-138-2-200301210-00014","volume":"138","author":"MA Crowther","year":"2003","unstructured":"Crowther MA, Kelton JG (2003) Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med 138:128\u2013134","journal-title":"Ann Intern Med"},{"issue":"19","key":"6021_CR9","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel TL, Neumann I, Ageno W et al (2020) American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 4(19):4693\u20134738","journal-title":"Blood Adv"},{"issue":"8","key":"6021_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1207541","volume":"368","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, AMPLIFY-EXT Investigators et al (2013) Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 368(8):699\u2013708","journal-title":"N Engl J Med."},{"issue":"13","key":"6021_CR11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","volume":"376","author":"JI Weitz","year":"2017","unstructured":"Weitz JI, Lensing AWA, Prins MH, EINSTEIN CHOICE Investigators et al (2017) Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med. 376(13):1211\u20131222","journal-title":"N Engl J Med."},{"key":"6021_CR12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/archinte.166.7.729","volume":"166","author":"WK Ho","year":"2006","unstructured":"Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW (2006) Risk of recurrent venous thromboembolism in patients with common thrombophilia: A systematic review. Arch Intern Med 166:729\u2013736","journal-title":"Arch Intern Med"},{"key":"6021_CR13","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1001\/jama.2009.853","volume":"301","author":"JB Segal","year":"2009","unstructured":"Segal JB, Brotman DJ, Necochea AJ, Emadi A, Samal L, Wilson LM, Crim MT (2009) Bass EB Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: A systematic review. JAMA 301:2472\u20132485","journal-title":"JAMA"},{"issue":"12","key":"6021_CR14","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJMra1700365","volume":"377","author":"JM Connors","year":"2017","unstructured":"Connors JM (2017) Thrombophilia Testing and Venous Thrombosis. N Engl J Med 377(12):1177\u20131187","journal-title":"N Engl J Med"},{"issue":"22","key":"6021_CR15","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","volume":"7","author":"S Middeldorp","year":"2023","unstructured":"Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, Coppens M, Houghton D, James AH, Lang E, Moll S, Myers T, Bhatt M, Chai-Adisaksopha C, Colunga-Lozano LE, Karam SG, Zhang Y, Wiercioch W, Sch\u00fcnemann HJ, Iorio A (2023) American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv 7(22):7101\u20137138","journal-title":"Blood Adv"},{"issue":"6","key":"6021_CR16","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","volume":"160","author":"SM Stevens","year":"2021","unstructured":"Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores LK (2021) Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest 160(6):e545\u2013e608","journal-title":"Chest"},{"key":"6021_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2152\/jmi.66.182","volume":"66","author":"S Yagi","year":"2019","unstructured":"Yagi S, Kagawa K, Fujimoto E, Sata M (2019) Recurrent venous thrombosis during direct oral anticoagulant therapy in a patient with protein S deficiency. J Med Investig JMI 66:182\u2013184","journal-title":"J Med Investig JMI"},{"key":"6021_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/MBC.0000000000000929","volume":"31","author":"J Lou","year":"2020","unstructured":"Lou J, Yin L, Ke X, Zhang L, Xu F, Liu Z (2020) A case-report of two patients with hereditary protein s deficiency treated by Rivaroxaban. Blood Coagul Fibrinolysis Int J Haemost Thromb. 31:405\u2013409","journal-title":"Blood Coagul Fibrinolysis Int J Haemost Thromb."},{"key":"6021_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12185-015-1898-6","volume":"103","author":"A Tripodi","year":"2016","unstructured":"Tripodi A, Martinelli I, Chantarangkul V, Clerici M, Artoni A, Passamonti S, Peyvandi F (2016) Thrombin Generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with Rivaroxaban. Int J Hematol 103:165\u2013172","journal-title":"Int J Hematol"},{"key":"6021_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jccase.2018.12.007","volume":"19","author":"Y Nojima","year":"2019","unstructured":"Nojima Y, Ihara M, Adachi H, Kurimoto T, Nanto S (2019) Efficacy and safety of apixaban in a patient with systemic venous thromboembolism associated with hereditary antithrombin deficiency. J Cardiol Cases 19:106\u2013109","journal-title":"J Cardiol Cases"},{"key":"6021_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1177\/1060028014533304","volume":"48","author":"RM Cook","year":"2014","unstructured":"Cook RM, Rondina MT, Horton DJ (2014) Rivaroxaban for the long-term treatment of spontaneous ovarian vein thrombosis caused by factor V leiden homozygosity. Ann Pharmacother 48:1055\u20131060","journal-title":"Ann Pharmacother"},{"key":"6021_CR22","first-page":"e11949","volume":"12","author":"RL Costa","year":"2020","unstructured":"Costa RL, Triggs M, Cole SE, Lacey J, Reddy S (2020) Anticoagulation therapy in a patient with heterozygous factor V Leiden and coexisting homozygous prothrombin gene mutations. Cureus 12:e11949","journal-title":"Cureus"},{"key":"6021_CR23","doi-asserted-by":"publisher","first-page":"e018917","DOI":"10.1161\/JAHA.120.018917","volume":"9","author":"E Campello","year":"2020","unstructured":"Campello E, Spiezia L, Simion C, Tormene D, Camporese G, Dalla Valle F, Poretto A, Bulato C, Gavasso S, Radu CM et al (2020) Direct oral anticoagulants in patients with inherited thrombophilia and venous thromboembolism: a prospective cohort study. J Am Heart Assoc 9:e018917","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"6021_CR24","doi-asserted-by":"publisher","first-page":"e2019044","DOI":"10.4084\/mjhid.2019.044","volume":"11","author":"A Serrao","year":"2019","unstructured":"Serrao A, Lucani B, Mansour D, Ferretti A, Baldacci E, Santoro C, Fo\u00e0 R, Chistolini A (2019) Direct oral anticoagulants in patients affected by major congenital thrombophilia. Mediterr J Hematol Infect Dis 11(1):e2019044","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"4","key":"6021_CR25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s11739-021-02917-3","volume":"17","author":"A Serrao","year":"2022","unstructured":"Serrao A, Assanto GM, Mormile R, Brescini M, Santoro C, Chistolini A (2022) Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients. Intern Emerg Med 17(4):1081\u20131085","journal-title":"Intern Emerg Med"},{"issue":"1","key":"6021_CR26","doi-asserted-by":"publisher","first-page":"e2024020","DOI":"10.4084\/MJHID.2024.020","volume":"16","author":"A Lagan\u00e0","year":"2024","unstructured":"Lagan\u00e0 A, Assanto GM, Masucci C et al (2024) Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban: results from a patient population with more than 2 years of median follow-up. Mediterr J Hematol Infect Dis. 16(1):e2024020","journal-title":"Mediterr J Hematol Infect Dis."}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06021-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06021-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06021-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T09:30:16Z","timestamp":1730712616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06021-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["6021"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06021-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical review and approval were waived for this study (observational retrospective) due to the retrospective design of the study, according to local laws.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was collected according to local practice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}